Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/6515
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHatzade, K M-
dc.contributor.authorTaile, V S-
dc.contributor.authorGaidhane, P K-
dc.contributor.authorUmare, V D-
dc.contributor.authorHaldar, A G M-
dc.contributor.authorIngle, V N-
dc.date.accessioned2009-11-10T10:41:40Z-
dc.date.available2009-11-10T10:41:40Z-
dc.date.issued2009-11-
dc.identifier.issn0975-0983(Online); 0376-4699(Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/6515-
dc.description1548-1557en_US
dc.description.abstractA convenient route to synthesize some new medicinally important 7-hydroxy-3-(3-oxo-3-arylprop-1-enyl)-chromones 2 is described by the interaction of 7-hydroxy-3-formyl chromone 1 with various substituted acetophenones which on condensation with 2,3,4,6-tetra-o-acetyl--D-glucopyranosyl bromide affords 2,3,4,6-tetra-o-acetyl--D-glucopyranosyloxy-3-(3-oxo-3-arylprop-1-enyl)-4H-chromen-4-ones 3. Later on deacetylation with anhydrous zinc acetate in methanol gives 7-o--D-glucopyranosyloxy-3-(3-oxo-3-arylprop-1-enyl)-4H-chromen-4-ones 4. These compounds are evaluated for their in vitro antimicrobial and antioxidant activity. The structures of these newly synthesized compounds are established by IR, NMR, mass spectra, elemental analysis and chemical analysis.en_US
dc.language.isoen_USen_US
dc.publisherCSIRen_US
dc.sourceIJC-B Vol.48B(11) [November 2009]en_US
dc.subjectChromonesen_US
dc.subject,-unsaturated carbonyl compoundsen_US
dc.subjectglucosylationen_US
dc.subjecto--D-glucosidesen_US
dc.subjectbiological activityen_US
dc.titleSynthesis and biological activities of new 7-o--D-glucopyranosyloxy-3-(3-oxo-3-arylprop-1-enyl)-chromonesen_US
dc.typeArticleen_US
Appears in Collections:IJC-B Vol.48B(11) [November 2009]

Files in This Item:
File Description SizeFormat 
IJCB 48B(11) 1548-1557.pdf158.66 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.